kentucky semaglutide stomach paralysis class action vomiting lawsuit in The 2 sides of Ozempic — weight loss success stories and health nightmares Ozempic Lawsuit 2026: Paralysis, – kentucky semaglutide stomach paralysis law

The FDA has received hundreds of adverse event reports associated with compounded GLP-1 medications, often involving dosing errors, improper formulations, or counterfeit products

Monitoring lipid levels helps assess overall cardiovascular health, particularly important given that many patients with type 2 diabetes have concurrent dyslipidemia

This approach may help support the bodys natural response while reducing the risk of reduced sensitivity over time

Shortages impacting access to glucagon-like peptide 1 receptor agonist products

GLP-1 RA use was associated with a higher risk of psoriasis compared with insulin (HR 1.17, 95% CI 1.101.25), biguanides (HR 1.14, 95% CI 1.071.23), and sulfonylureas (HR 1.34, 95% CI 1.201.50), while no significant differences were observed versus SGLT2i (HR 0.99, 95% CI 0.911.07) or thiazolidinediones (HR 1.05, 95% CI 0.641.71) ( Figure 3A )